Profile data is unavailable for this security.
About the company
Synthaverse SA formerly known as Biomed Lublin Wytwornia Surowic i Szczepionek SA is a Poland-based company operating in the Life Science industry, dealing primarily with the production of medicines. The Company focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The Company offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The Company supplies its products to 50 countries around the world.
- Revenue in PLN (TTM)60.51m
- Net income in PLN3.62m
- Incorporated2010
- Employees239.00
- LocationSynthaverse SAul. Uniwersytecka 10LUBLIN 20-029PolandPOL
- Phone+48 815338221
- Fax+48 815338060
- Websitehttps://synthaverse.pl/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioMaxima SA | 48.67m | 361.00k | 68.77m | 115.00 | 188.79 | 1.46 | 22.05 | 1.41 | 0.0869 | 0.0869 | 11.68 | 11.22 | 0.6653 | 1.88 | 4.77 | 423,217.40 | 0.4935 | 16.44 | 0.5661 | 22.44 | 48.78 | 40.72 | 0.7417 | 12.84 | 1.06 | 0.9304 | 0.214 | -- | -67.22 | 9.13 | -97.97 | -- | 0.7404 | -- |
| Onesano SA | 12.34m | -6.34m | 80.37m | 55.00 | -- | 5.69 | -- | 6.51 | -0.0962 | -0.0962 | 0.1873 | 0.2144 | 0.5649 | 1.41 | 6.78 | 232,811.30 | -29.02 | -28.15 | -35.92 | -- | 41.75 | 50.87 | -51.38 | -29.92 | 2.77 | -- | 0.0349 | -- | 0.7093 | 28.40 | -61.92 | -- | 101.90 | -- |
| Sds Optic SA | 530.40k | -7.39m | 116.73m | -- | -- | 16.65 | -- | 220.08 | -1.30 | -1.30 | 0.0928 | 1.19 | 0.054 | -5.91 | 2.11 | -- | -75.38 | -- | -94.39 | -- | 167.64 | -- | -1,395.87 | -- | 4.85 | -- | 0.00 | -- | -99.59 | -- | -85.26 | -- | -- | -- |
| Urteste SA | 0.00 | -5.59m | 131.10m | -- | -- | 4.73 | -- | -- | -4.52 | -4.52 | 0.00 | 19.68 | 0.00 | 3.86 | -- | -- | -30.78 | -- | -32.71 | -- | -- | -- | -- | -- | 17.11 | -- | 0.0221 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
| Genomtec SA | 1.00k | -9.01m | 137.53m | -- | -- | 16.57 | -- | 137,533.50 | -0.8037 | -0.8037 | 0.00009 | 0.6773 | 0.00007 | 15.45 | 0.0008 | -- | -65.01 | -- | -80.98 | -- | -81,000.00 | -- | -901,300.00 | -- | 2.11 | -46.67 | 0.1613 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
| Poltreg SA | 900.00k | -15.65m | 217.32m | 23.00 | -- | 2.58 | -- | 241.46 | -3.36 | -3.36 | 0.193 | 18.07 | 0.0073 | 43.39 | 3.20 | 39,560.44 | -12.68 | -6.51 | -14.06 | -7.35 | -1,242.56 | -391.38 | -1,738.56 | -449.24 | 4.90 | -- | 0.0868 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
| Molecure SA | 1.31m | -18.31m | 246.48m | 111.00 | -- | 1.57 | -- | 188.36 | -1.17 | -1.17 | 0.0847 | 9.34 | 0.0085 | -- | 0.2818 | 11,788.92 | -11.94 | 2.52 | -12.47 | 2.64 | -25.76 | 97.54 | -1,398.86 | 12.84 | -- | -- | 0.0434 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
| Bioceltix SA | 0.00 | -12.73m | 263.46m | -- | -- | 18.51 | -- | -- | -3.45 | -3.45 | 0.00 | 3.45 | 0.00 | 170.52 | -- | -- | -112.58 | -- | -140.07 | -- | -- | -- | -- | -- | 5.96 | -- | 0.0071 | -- | -- | -- | -102.87 | -- | -- | -- |
| Mabion SA | 146.11m | 42.34m | 288.66m | 226.00 | 6.82 | 2.13 | 5.81 | 1.98 | 2.62 | 2.62 | 9.04 | 8.37 | 0.7084 | 4.59 | 8.68 | 646,495.60 | 20.53 | -7.19 | 28.38 | -16.79 | 75.66 | 58.10 | 28.98 | -14.27 | 1.93 | 25.96 | 0.1513 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
| BIOTON SA | 184.75m | -2.63m | 303.10m | 358.00 | -- | 0.504 | 9.27 | 1.64 | -0.0306 | -0.0306 | 2.15 | 7.00 | 0.2291 | 1.00 | 6.74 | 516,050.30 | -0.3261 | -1.99 | -0.3999 | -2.47 | 34.77 | 45.33 | -1.42 | -8.61 | 0.184 | 1.16 | 0.0933 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
| Captor Therapeutics SA | 16.16m | -65.79m | 308.09m | 104.00 | -- | 5.68 | -- | 19.06 | -15.07 | -15.07 | 3.63 | 12.86 | 0.1741 | -- | 5.14 | 155,413.50 | -70.87 | -- | -89.64 | -- | 54.29 | -- | -407.07 | -- | -- | -- | 0.0458 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
| Synthaverse SA | 60.51m | 3.62m | 323.69m | 239.00 | 96.18 | 3.12 | 31.59 | 5.35 | 0.0516 | 0.0516 | 0.8605 | 1.59 | 0.2601 | 1.67 | 3.18 | 253,192.50 | 1.56 | 3.53 | 1.83 | 4.32 | 60.39 | 55.62 | 5.98 | 9.59 | 0.8723 | 3.32 | 0.4038 | -- | 16.32 | 12.66 | -21.76 | -- | 111.77 | -- |
| Scope Fluidics SA | 93.00k | -22.60m | 477.04m | 40.00 | -- | 6.44 | -- | 5,129.44 | -8.29 | -8.29 | 0.0341 | 27.18 | 0.0009 | 2.94 | 0.0337 | 2,325.00 | -21.76 | 52.74 | -22.74 | 57.32 | -2,022.58 | -420.87 | -24,304.30 | 30,134.78 | 13.86 | -- | 0.0299 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
Data as of Jun 07 2024. Currency figures normalised to Synthaverse SA's reporting currency: Polish New Zloty PLN
0.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| PKO TFI SAas of 29 Sep 2023 | 14.38k | 0.02% |
| IPOPEMA TFI SAas of 30 Jun 2023 | 7.46k | 0.01% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 1.24k | 0.00% |
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
